Yalan Yu

Plasma miR-92a-2 as a biomarker for small cell lung cancer.

Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker.

Fluorescence hybridization comparison of the prognostic factors in adult and pediatric acute lymphoblastic leukemia: A retrospective analysis of 282 cases.

Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.

SF3B1 Mutation but Not Ring Sideroblasts Identifies a Specific Group of Myelodysplastic Syndrome-Refractory Cytopenia With Multilineage Dysplasia.

The effect of miR-223 on cellular behaviour in non-5q myelodysplastic syndromes through targeting RPS14.

Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19.

Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study.

Reduced miR-16 levels are associated with VEGF upregulation in high-risk myelodysplastic syndromes.

Next-generation sequencing redefines the diagnosis of triple-negative myeloproliferative neoplasms.

A new workflow on bone marrow aspiration and biopsy during the COVID-19 pandemic.